Ascendis Pharma A (ASND) Treasury Shares (2021 - 2026)
Ascendis Pharma A (ASND) posted Treasury Shares of $1.1 million for Q4 2021.
Analysis
Ascendis Pharma A (ASND) Treasury Shares (2021 - 2026) Analysis & Trends
Ascendis Pharma A has reported Treasury Shares for 2 years, with the latest figure at -$60.7 million in Q1 2026.
- Quarterly Treasury Shares changed N/A year-over-year to $1.1 million in Q4 2021, while the trailing twelve-month figure through Dec 2021 was $1.1 million (changed N/A YoY) and the FY2021 annual result came in at $1.1 million, changed N/A from the prior year.
- Treasury Shares retreated to -$60.7 million in Q1 2026 per ASND's latest filing, from -$18.3 million in the prior quarter.
- Over five years, Treasury Shares peaked at $1.1 million in Q4 2021 and troughed at $1.1 million in Q4 2021.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 36.40 Mn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | - |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | - |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | 2.72 Mn |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | - |
| 10 | Ascendis Pharma A | 16.39 Bn | 15.45 Bn | 362.22 Mn | -120.20 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -120.20 Mn |
| Jun 30, 2026 | -120.20 Mn |
| Mar 31, 2026 | -60.71 Mn |
| Mar 31, 2026 | -60.71 Mn |
| Jun 30, 2025 | -19.69 Mn |
| Jun 30, 2025 | -19.69 Mn |
| Mar 31, 2025 | -18.30 Mn |
| Mar 31, 2025 | -18.30 Mn |
| Dec 31, 2021 | 1.14 Mn |
| Dec 31, 2021 | 1.14 Mn |